Følg
Sarah Kammerer
Sarah Kammerer
Brandenburg University of Technology Cottbus-Senftenberg
Verifisert e-postadresse på b-tu.de
Tittel
Sitert av
Sitert av
År
Piezo1 forms mechanosensitive ion channels in the human MCF-7 breast cancer cell line
C Li, S Rezania, S Kammerer, A Sokolowski, T Devaney, A Gorischek, ...
Scientific reports 5 (1), 8364, 2015
1802015
Phycocyanin from Arthrospira platensis as Potential Anti-Cancer Drug: Review of In Vitro and In Vivo Studies
S Braune, A Krüger-Genge, S Kammerer, F Jung, JH Küpper
Life 11 (2), 91, 2021
1122021
Human hepatocyte systems for in vitro toxicology analysis
S Kammerer, JH Küpper
Journal of Cellular Biotechnology 3 (2), 85-93, 2018
532018
Three-dimensional liver culture systems to maintain primary hepatic properties for toxicological analysis in vitro
S Kammerer
International journal of molecular sciences 22 (19), 10214, 2021
422021
ATP-based cell viability assay is superior to trypan blue exclusion and XTT assay in measuring cytotoxicity of anticancer drugs Taxol and Imatinib, and proteasome inhibitor MG …
E Nowak, S Kammerer, JH Küpper
Clinical hemorheology and microcirculation 69 (1-2), 327-336, 2018
342018
Multifactorial resistance to aminopeptidase inhibitor prodrug CHR2863 in myeloid leukemia cells: down-regulation of carboxylesterase 1, drug sequestration in lipid droplets and …
SE Verbrugge, M Al, YG Assaraf, S Kammerer, DMSH Chandrupatla, ...
Oncotarget 7 (5), 5240, 2015
342015
Synthesis of cyclophosphamide metabolites by a peroxygenase from Marasmius rotula for toxicological studies on human cancer cells
S Steinbrecht, J Kiebist, R König, M Thiessen, KU Schmidtke, ...
AMB Express 10, 1-13, 2020
262020
Metabolic activity testing can underestimate acute drug cytotoxicity as revealed by HepG2 cell clones overexpressing cytochrome P450 2C19 and 3A4
S Steinbrecht, R König, KU Schmidtke, N Herzog, K Scheibner, ...
Toxicology 412, 37-47, 2019
262019
Brivanib Exhibits Potential for Pharmacokinetic Drug–Drug Interactions and the Modulation of Multidrug Resistance through the Inhibition of Human ABCG2 Drug Efflux Transporter …
J Hofman, A Sorf, D Vagiannis, S Sucha, S Kammerer, JH Küpper, ...
Molecular pharmaceutics 16 (11), 4436-4450, 2019
252019
Ensartinib (X-396) effectively modulates pharmacokinetic resistance mediated by ABCB1 and ABCG2 drug efflux transporters and CYP3A4 biotransformation enzyme
D Vagiannis, E Novotna, A Skarka, S Kammerer, JH Küpper, S Chen, ...
Cancers 12 (4), 813, 2020
242020
KCNJ3 is a new independent prognostic marker for estrogen receptor positive breast cancer patients
S Kammerer, A Sokolowski, H Hackl, D Platzer, SW Jahn, A El-Heliebi, ...
Oncotarget 7 (51), 84705, 2016
212016
Interactions of alectinib with human ATP-binding cassette drug efflux transporters and cytochrome P450 biotransformation enzymes: effect on pharmacokinetic multidrug resistance
J Hofman, A Sorf, D Vagiannis, S Sucha, E Novotna, S Kammerer, ...
Drug Metabolism and Disposition 47 (7), 699-709, 2019
202019
Real time monitoring of oxygen uptake of hepatocytes in a microreactor using optical microsensors
C Gehre, M Flechner, S Kammerer, JH Küpper, CD Coleman, GP Püschel, ...
Scientific reports 10 (1), 13700, 2020
182020
Effects of acrolein in comparison to its prodrug cyclophosphamide on human primary endothelial cells in vitro
S Lau, R Rangarajan, C Philidet, A Krüger-Genge, S Braune, S Kammerer, ...
Toxicology in Vitro 62, 104685, 2020
182020
HepG2 cells with recombinant cytochrome P450 enzyme overexpression: Their use and limitation as in vitro liver model
S Steinbrecht, S Kammerer, JH Küpper
Journal of Cellular Biotechnology 5 (1), 55-64, 2019
162019
Overexpression of KCNJ3 gene splice variants affects vital parameters of the malignant breast cancer cell line MCF-7 in an opposing manner
S Rezania, S Kammerer, C Li, B Steinecker-Frohnwieser, A Gorischek, ...
BMC cancer 16, 1-15, 2016
162016
NADPH-cytochrome P450 reductase expression and enzymatic activity in primary-like human hepatocytes and HepG2 cells for in vitro biotransformation studies
C Schulz, S Kammerer, JH Küpper
Clinical hemorheology and microcirculation 73 (1), 249-260, 2019
152019
HepG2-1A2 C2 and C7: Lentivirus vector-mediated stable and functional overexpression of cytochrome P450 1A2 in human hepatoblastoma cells
S Steinbrecht, N Pfeifer, N Herzog, N Katzenberger, C Schulz, ...
Toxicology letters 319, 155-159, 2020
132020
Alisertib shows negligible potential for perpetrating pharmacokinetic drug-drug interactions on ABCB1, ABCG2 and cytochromes P450, but acts as dual-activity resistance …
D Vagiannis, Y Zhang, Y Budagaga, E Novotna, A Skarka, S Kammerer, ...
Toxicology and Applied Pharmacology 434, 115823, 2022
122022
Tepotinib inhibits several drug efflux transporters and biotransformation enzymes: the role in drug-drug interactions and targeting cytostatic resistance in vitro and ex vivo
D Vagiannis, Y Budagaga, A Morell, Y Zhang, E Novotná, A Skarka, ...
International Journal of Molecular Sciences 22 (21), 11936, 2021
82021
Systemet kan ikke utføre handlingen. Prøv på nytt senere.
Artikler 1–20